Brought to you by 
Good Start Genetics gets $14mm through its Series B venture round
06 Apr 2012
Executive Summary
Good Start Genetics Inc. (molecular diagnostics) has raised $14mm through its Series B venture round. Current shareholders OrbiMed Advisors, Safeguard Scientifics, and SV Life Sciences led. The company will use some of the proceeds for commercial activities for its preconception carrier screening tests for cystic fibrosis, Gaucher’s disease, and sickle cell anemia.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Good Start Genetics gets $14mm through its Series B venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice